| pubmed-article:17998283 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17998283 | lifeskim:mentions | umls-concept:C1140680 | lld:lifeskim |
| pubmed-article:17998283 | lifeskim:mentions | umls-concept:C0032854 | lld:lifeskim |
| pubmed-article:17998283 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
| pubmed-article:17998283 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:17998283 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:17998283 | lifeskim:mentions | umls-concept:C1561558 | lld:lifeskim |
| pubmed-article:17998283 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
| pubmed-article:17998283 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
| pubmed-article:17998283 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:17998283 | pubmed:dateCreated | 2008-2-28 | lld:pubmed |
| pubmed-article:17998283 | pubmed:abstractText | P63 belongs to the 'p53 family' whose role in cancer progression has been recently revisited in light of the plethora of splicing variants that are generated. We analyzed the expression of the full-length TAp63 gene and its dominant-negative form deltaNp63 in ovarian cancer biopsies to correlate their expression with clinical outcome. | lld:pubmed |
| pubmed-article:17998283 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17998283 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17998283 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17998283 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17998283 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17998283 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17998283 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17998283 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17998283 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17998283 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17998283 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:17998283 | pubmed:issn | 1569-8041 | lld:pubmed |
| pubmed-article:17998283 | pubmed:author | pubmed-author:FossatoLL | lld:pubmed |
| pubmed-article:17998283 | pubmed:author | pubmed-author:MarianiPP | lld:pubmed |
| pubmed-article:17998283 | pubmed:author | pubmed-author:CompagnoniAA | lld:pubmed |
| pubmed-article:17998283 | pubmed:author | pubmed-author:MarchiniSS | lld:pubmed |
| pubmed-article:17998283 | pubmed:author | pubmed-author:BrogginiMM | lld:pubmed |
| pubmed-article:17998283 | pubmed:author | pubmed-author:CattaneoDD | lld:pubmed |
| pubmed-article:17998283 | pubmed:author | pubmed-author:MarrazzoEE | lld:pubmed |
| pubmed-article:17998283 | pubmed:author | pubmed-author:LissoniA AAA | lld:pubmed |
| pubmed-article:17998283 | pubmed:author | pubmed-author:MarabeseMM | lld:pubmed |
| pubmed-article:17998283 | pubmed:author | pubmed-author:FruscioRR | lld:pubmed |
| pubmed-article:17998283 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:17998283 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:17998283 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17998283 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17998283 | pubmed:pagination | 501-7 | lld:pubmed |
| pubmed-article:17998283 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:17998283 | pubmed:meshHeading | pubmed-meshheading:17998283... | lld:pubmed |
| pubmed-article:17998283 | pubmed:meshHeading | pubmed-meshheading:17998283... | lld:pubmed |
| pubmed-article:17998283 | pubmed:meshHeading | pubmed-meshheading:17998283... | lld:pubmed |
| pubmed-article:17998283 | pubmed:meshHeading | pubmed-meshheading:17998283... | lld:pubmed |
| pubmed-article:17998283 | pubmed:meshHeading | pubmed-meshheading:17998283... | lld:pubmed |
| pubmed-article:17998283 | pubmed:meshHeading | pubmed-meshheading:17998283... | lld:pubmed |
| pubmed-article:17998283 | pubmed:meshHeading | pubmed-meshheading:17998283... | lld:pubmed |
| pubmed-article:17998283 | pubmed:meshHeading | pubmed-meshheading:17998283... | lld:pubmed |
| pubmed-article:17998283 | pubmed:meshHeading | pubmed-meshheading:17998283... | lld:pubmed |
| pubmed-article:17998283 | pubmed:meshHeading | pubmed-meshheading:17998283... | lld:pubmed |
| pubmed-article:17998283 | pubmed:meshHeading | pubmed-meshheading:17998283... | lld:pubmed |
| pubmed-article:17998283 | pubmed:meshHeading | pubmed-meshheading:17998283... | lld:pubmed |
| pubmed-article:17998283 | pubmed:meshHeading | pubmed-meshheading:17998283... | lld:pubmed |
| pubmed-article:17998283 | pubmed:meshHeading | pubmed-meshheading:17998283... | lld:pubmed |
| pubmed-article:17998283 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:17998283 | pubmed:articleTitle | DeltaNp63 expression is associated with poor survival in ovarian cancer. | lld:pubmed |
| pubmed-article:17998283 | pubmed:affiliation | Laboratory of Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. marchini@marionegri.it | lld:pubmed |
| pubmed-article:17998283 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17998283 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:8626 | entrezgene:pubmed | pubmed-article:17998283 | lld:entrezgene |
| entrez-gene:246334 | entrezgene:pubmed | pubmed-article:17998283 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:17998283 | lld:entrezgene |
| lhgdn:association:1615 | lhgdn:found_in | pubmed-article:17998283 | lld:lhgdn |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17998283 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17998283 | lld:pubmed |
